An open label, single-arm, phase II multicenter study of the safety and efficacy of CG0070 oncolytic vector regimen in patients with BCG-unresponsive non–muscle-invasive bladder cancer: Interim results

著者: Vignesh T. Packiam, Donald L. Lamm, Daniel A. Barocas, Andrew Trainer, Benjamin Fand, Ronald L. Davis, William R. Clark, Michael Kroeger, Igor Dumbadze, Karim Chamie, A. Karim Kader, Dominic Curran, John Gutheil, Arthur Kuan, Alex Yeung, Gary D. Steinberg - Urologic Oncology Seminars and Original Investigations 2017 被引用: 243